chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient. Oct, 15, 2021: 27  year old female patient received her second COVID 19 vaccine. Patient stated before the vaccine was administered that she tends to feel become anxious with needles but had no previous history of vasovagal responses. After the vaccine was administered the vaccinator asked the patient how she was feeling and the patient stated she was "fine".  Patient was given discharge instructions and told to sit in the observation area. It was there that the patient stated "she was feeling nauseous and hot" approx. 5 minutes after receiving the vaccine. Patient.  Patient stated that she had had no food intake since dinner the previous night. Vital signs were  B/P :141/83, RR: 12, HR: 79, Spo2: 100 and A&O x3. Patient taken to the Emergency Room based off hospital protocol.
Slight swelling of L neck, face and lip on the left side (same side as flu shot injection in arm).
On April 3rd 4PM I had shortness of breath and dizziness. I called the online DR telehealth. I then went to an immediate care where I was sent to the hospital. At the ER I was diagnosed with pulmonary emboli across both lungs. I was then admitted to the hospital. In the hospital, they did an echo which was normal and a stress test. I was put on Eliquis. I was discharged on Monday April 5th  A few days later, I went back to the ER because I had fallen after feeling very dizzy. That was on Tuesday April 6th. They did a scan of my head which was fine so I was sent home. They asked me to follow up with my pulmonologist and my PCP.
On Thanksgiving day, November 25, 2021, I suffered for the first time severe stroke-like symptoms (total numbness of left arm, radiating down through left leg, radiating up to neck and face).  Contacted 911, which transported me to the Hospital.  Entire battery of tests was run (CT Scan, MRI, CAT Scan, Ultrasounds of heart and neck veins).  Final diagnosis of the physicians on duty was that I had a TIA (mini-stroke).  Discharged on November 26, 2021.  Subscriptions for aspirin and Plavix were given (blood thinners to avoid blood clotting) and Lipitor.
Systemic: Fainting / Unresponsive-Medium, Additional Details: Patient became light headed and fainted.  After a few seconds patient became alert but was not feeling well enough to stand or sit.  Paramedics were called to evaluate patient.  After evaluation, it was determined that patient didn't need medical treatment and pt was able to go home on her own after about 20 minutes
This spontaneous report was received from a healthcare student and refers to a 67 year old female patient. The patient's pertinent medical history and concurrent conditions were not provided. On 13-JUL-2015, the patient was vaccinated with a 0.65 ml dose of ZOSTAVAX, lot # L003216, expiration date 30-APR-2016, subcutaneous. ZOSTAVAX was reconstituted on its sterile diluent, lot number reported as L001656, expiration date 20-DEC-2015. There was no concomitant medication. On 13-JUL-2015, immediately after receiving ZOSTAVAX, the patient experienced injection site urticaria described as three welts with pus around the injection site. There were no laboratory diagnostics studies performed. The patient sought medical attention in the pharmacy at the time of the event. The patient received BENADRYL and after four to five days, on approximately 18-JUL-2015, the injection site urticaria resolved. The relatedness of the event to ZOSTAVAX was not provided. Additional information has been requested.
Weakness, sore, aching, unable to lay on arm.  Applied heat, may help some.
After the first shot: little fatigue and arm soreness After second shot: fever, chills, nauseous, extreme fatigue, headache, muscle aches all over body
Thigh swollen, red hot to touch, "flaming red" Very painful; Occurred almost immediately p/1st inject; Tx APAP & cold compresses;
Chest pain; Very dizzy; Woke up very Weak; arm very sore; severe body ache; Fever 101.5 F; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (Chest pain), DIZZINESS (Very dizzy), ASTHENIA (Woke up very Weak), PAIN IN EXTREMITY (arm very sore) and PAIN (severe body ache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer. Concurrent medical conditions included Psoriasis. Concomitant products included TAMOXIFEN for Breast cancer, APREMILAST (OTEZLA) for Psoriasis.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In December 2020, the patient experienced PAIN (severe body ache) and PYREXIA (Fever 101.5 F). On 29-Dec-2020, the patient experienced PAIN IN EXTREMITY (arm very sore). On 30-Dec-2020, the patient experienced DIZZINESS (Very dizzy) and ASTHENIA (Woke up very Weak). On 30-Dec-2020 at 11:00 PM, the patient experienced CHEST PAIN (Chest pain). On 31-Dec-2020, CHEST PAIN (Chest pain), DIZZINESS (Very dizzy), ASTHENIA (Woke up very Weak), PAIN IN EXTREMITY (arm very sore), PAIN (severe body ache) and PYREXIA (Fever 101.5 F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, Body temperature: 101.5 °F. In December 2020, Electrocardiogram: ??dec2020 Normal. In December 2020, Myocardial necrosis marker: Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment for the event included paracetamol and morphine.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Next day started with arm soreness when woke up. A couple hours started having headache, chills, arm soreness, numbness and tingling in hands for a couple minutes, skin sensitivity, stomach upset, temperature in the evening up to 102.6,  full body aches, and fatigue.
Severe headache about 7 hours after vaccination,  also severe body aches and chills responded to ibuprofen
This spontaneous report was received from a nurse refers to multiple unspecified patients of unknown age and gender. Information regarding patients' medical history, current conditions and concomitant medications were not reported. On multiple unknown dates, the patients received improperly stored GARDASIL 9 (lot # N012093, expiry date: 13-JAN-2020) via unspecified routes, for prophylaxis. Nurse reported that the vaccine underwent temperature excursion at 32-35 degree Fahrenheit (35F) for 24 hours. There were multiple previous temperature excursions: 32 to 35 degree Fahrenheit (35F) for 12 hours, 32 to 35 degree Fahrenheit (35F) for 12 hours, 32 to 35 degree Fahrenheit (35F) for 12 hours, 32 to 35 degree Fahrenheit (35F) for 12 hours, 32 to 35 degree Fahrenheit (35F) for 12 hours, 32 to 35 degree Fahrenheit (35F) for 24 hours. No digital data logger was reported. No side effects were reported. This is one of the three reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1708USA005455: US-009507513-1708USA006124.
Sluggish; No energy; Sore arm; No appetite; In bed for 3 days; Fever; This spontaneous case was reported by a consumer and describes the occurrence of SLUGGISHNESS (Sluggish), ASTHENIA (No energy), PAIN IN EXTREMITY (Sore arm), DECREASED APPETITE (No appetite) and VACCINATION COMPLICATION (In bed for 3 days) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LORAZEPAM for Sleep disorder NOS.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SLUGGISHNESS (Sluggish), ASTHENIA (No energy), PAIN IN EXTREMITY (Sore arm), DECREASED APPETITE (No appetite), VACCINATION COMPLICATION (In bed for 3 days) and PYREXIA (Fever). At the time of the report, SLUGGISHNESS (Sluggish), ASTHENIA (No energy), PAIN IN EXTREMITY (Sore arm), DECREASED APPETITE (No appetite), VACCINATION COMPLICATION (In bed for 3 days) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided by reporter.   This case was linked to MOD-2021-239170 (Patient Link).
10/26/12 received Flu Vaccine. 10/27/12 Awoke in AM unable to stand, legs numb from knees down, stabbing pains, burning in feet. Father carried her to car and transported her to ER. After six hours diagnosed her with paresthesia and sent her to Hospital for MRI which showed no injury to spine. Sent her home to follow up with doctor who gave flu shot. She became wheelchair bound. 10/31/12 Returned to Dr.'s office where flu shot was given. He did blood work and became suspect of Guillain Barre since she showed low levels of Creatine Kinase. Referred her to a neurologist for testing. Two weeks later Neurologist ruled out Guillain Barre "since she was not on a ventilator". Frustrated her family made appt. with a clinic in another state for further treatment. 11/5/12 Dr. at pain management ordered physical therapy, fentanyl patch and cream for burning, stabbing pain in feet. He would later put her on the drug GRALISE. 11/8/12 Physical Rehabilitation began physical therapy two to three times a week. By this time she had regained use of right leg and could stand on right leg with help to enter shower and bed. She was able to interchange between the wheel chair and a walker for short distances with a high stepping gait to clear her left foot. Without the walker she needs assistance to keep her balance. Goes up and down stairs by using her arms crawling on her bottom. She also has PT exercises to perform at home. Nov 12-Dec 12 Clinic in another state, under the care of Neurologists, she had numerous testing which included a lumbar puncture which ruled out MS, MD and Guillain Barre. In final notes which are included, they state that there is a possibility that this represented some kind of reaction to the flu vaccine. Suggested that she remain there for further treatment or return home for physical therapy under her doctor's care at home. 12/20/12 Returned home for further treatment. Her leg was extremely unstable and she fell fracturing her left ankle. Delayed PT until Jan 29th. Presently still under care of Pain Management for pain and Physical therapy. Making small steps of gaining use of legs.
very sick; Initial information was received on 17-Dec-2020 regarding an unsolicited valid non-serious social media case from a consumer.  This case involves patient (unknown demography) who was very sick (illness), while the patient received INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious was very sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE. It was reported that, had not taken flu shot since, nor have had the flu since then.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
Approximately 15 minutes after receiving flu vaccine, child return complaining of elevated wheezing, palms itching and stomach ache. He developed some perioral cyanosis. He was given oral Benadryl, epinephrine, xopenex mininebulizer and oxygen. He was taken by EMS to hospital where he received systemic steroids and ongoing nebulizer treatment.
less than a minute after injection burning in arm at injection site, then felt warm and flushed all over like getting CT scan dye.metallic taste in mouth. thickness feeling in throat. throat itching. headache. Following morning woke up with dysphagia and dramatic voice change
This spontaneous report as received from a nurse refers to a patient of unknown age. The nurse reported that a patient received the first dose of GARDASIL on 09-DEC-2009, the second dose of GARDASIL on 12-FEB-2010 and was in the office to receive the third dose of GARDASIL on 04-FEB-2013. It was unknown if the patient had sought medical attention. No adverse event reported. Additional information has been requested.
arm hot at injection site and surrounding deltoid muscle; arm red at injection site and surrounding deltoid muscle; sore at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 8th September 2021, the patient received the 1st dose of Shingrix (intramuscular). On 8th September 2021, 1 hr after receiving Shingrix, the patient experienced injection site pain. On 13th September 2021, the patient experienced feeling hot and localized erythema. On an unknown date, the outcome of the injection site pain, feeling hot and localized erythema were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, feeling hot and localized erythema to be related to Shingrix.  Additional details were provided are as follows: The case was reported by patient herself. The patient received a dose of Shingrix in the left arm and her arm was sore at the injection site when she received the vaccine. On 13th September 2021, the patient experienced that her arm was hot and red at the injection site and surrounding area of the left deltoid muscle. The patient did nit gave permission to contact health care professional and did not want GlaxoSmithKline to contact her. The reporter did not consented to follow-up.
Not a constriction in her throat that she felt with anaphylaxis.; Itching of the scalp; Extreme burning on the tip of the tongue; The hives on her back; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (The hives on her back), OROPHARYNGEAL DISCOMFORT (Not a constriction in her throat that she felt with anaphylaxis.), PRURITUS (Itching of the scalp) and TONGUE DISCOMFORT (Extreme burning on the tip of the tongue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy and Shellfish allergy.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced URTICARIA (The hives on her back). On an unknown date, the patient experienced OROPHARYNGEAL DISCOMFORT (Not a constriction in her throat that she felt with anaphylaxis.), PRURITUS (Itching of the scalp) and TONGUE DISCOMFORT (Extreme burning on the tip of the tongue). On 10-Feb-2021, OROPHARYNGEAL DISCOMFORT (Not a constriction in her throat that she felt with anaphylaxis.) had resolved. On 03-Mar-2021, URTICARIA (The hives on her back) had resolved. At the time of the report, PRURITUS (Itching of the scalp) and TONGUE DISCOMFORT (Extreme burning on the tip of the tongue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Soon after the injection I experienced tinnitus. It has persisted chronically until now. There have been some times when the ringing wasn't as pronounced but currently I would describe it as loud and persistent.
Extreme dizziness, bad Headache, Nausea, Extreme Vomiting for 3 days (7-9 times per day) Water,  banana, applesauce was only consumed on 4th day. Adverse reaction lasted total for 5 days.
Twitching, convulsing for couple of seconds. Then patient fainted for about a couple of seconds and twitched again for another seconds (less than first onset). Patient was confused and disoriented for a couple of seconds after waking up. We had emergency allergy kit ready/ benadryl injection ready/ and called 911 as soon as she started twitching. Patient was sitting already, so we elevated her legs onto another chair. EMS came and took control of the situation.
Large red itchy patch at injection site, started small and is now the size of a softball.; Large red itchy patch at injection site, started small and is now the size of a softball.; Injection site was very raised and painful also.; Injection site was very raised and painful also.; Had dizziness and a 102 fever for 2.5 days; Had dizziness and a 102 fever for 2.5 days; Had swollen lymph node in left armpit and armpit pain.; Had swollen lymph node in left armpit and armpit pain.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8734) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient previously took penicillin for unknown indication and experienced penicillin allergy. Concomitant medications taken within two weeks of vaccination included fluoxetine hydrochloride (PROZAC), spironolactone (MANUFACTURER UNKNOWN) and buspirone hydrochloride (BUSPAR) all from unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep7534) via an unspecified route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 06:00, the patient experienced large red itchy patch at injection site, started small and was the size of a softball at the time of report. Injection site was very raised and painful also. The patient had dizziness and a 102 (units unspecified) fever for 2.5 days. The patient had swollen lymph node in left armpit and armpit pain. It had been 6 days post injection at the time of report and most symptoms had subsided except pain/redness/itchiness at injection site. The current remaining symptoms were mild. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The patient underwent Rapid test for COVID-19 via nasal swab on 10Apr2021 and the result was negative. The clinical outcome of the events large red itchy patch at injection site, started small and was the size of a softball at the time of report, injection site was very raised and painful also, dizziness and a 102 (units unspecified) fever for 2.5 days, swollen lymph node in left armpit and armpit pain was resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Fever and chills lasting approximately 2-3 hours that occurred approximately 12 hours after receiving the booster.  During that timeframe episode, I also experienced several rounds of diarrhea and one round of simultaneous diarrhea and vomiting. Arm soreness also increased around this time and had been milder earlier in the day.
At injection site:  Swelling, redness, temperature = Hot to touch, reaction spread to the size of a softball.
Adverse effect of vaccine Quality: headache, fever up to 102, body ache, fatigue, N without V, redness and swelling to injection  site, itching Severity: moderate Timing: continuous Duration: 4 days Associated signs and symptoms: Denies Swelling of face, lips, mouth, eyelids Denies chest pain, SOB, Wheezing, abd pain, Severe, headaches, dizziness
On May 9 I woke up and could not see out of my left eye.  I went to the eye doctor and discovered an artery burst in my eye that was causing my lost vision.  My eye doctor remcommended that I investigate why this happened becasue I am young and healthy.  The eye doctor order some labs, those tests came back good.  No explanation why my artery burst.  I went to my primary card doctor and she is researching and ordering more labs.  She recommened I report this as a possible side effect to the vaccine.  I am still unable to see completely out of my left eye.  I am having monthly injections hoping to improve my vision.
Lymphadenopathy; This is a spontaneous report from a contactable nurse (patient). A 30-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the left arm on 29Dec2020 at 13:45 (at the age of 30-years-old) as a single dose for Covid-19 vaccination. Medical history included hypertension from an unknown date. The patient was allergic to penicillin. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient was not tested for COVID-19 post vaccination. The patient did receive other medications within 2 weeks of the vaccination (unspecified). The patient did not receive other vaccines within four weeks prior to the vaccination. On 30Dec2020 at 15:00, the patient experienced Lymphadenopathy. Therapeutic measures were not taken for the Lymphadenopathy. The clinical outcome of the event Lymphadenopathy was recovering.  Information on the lot/batch number has been requested.
Sore Arm; slight rash on the arm/rash from his knees down; This spontaneous case was reported by a consumer and describes the occurrence of RASH (slight rash on the arm/rash from his knees down) and MYALGIA (Sore Arm) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced RASH (slight rash on the arm/rash from his knees down). On an unknown date, the patient experienced MYALGIA (Sore Arm). The patient was treated with CORTISONE ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, RASH (slight rash on the arm/rash from his knees down) and MYALGIA (Sore Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter  Treatment medication includes Anti histamines   This case was linked to MOD-2021-045039 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow-up received: Updated reporter address details and event information "rash from his knees down".
Systemic: Chills-Mild, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Nausea-Mild, Systemic: Weakness-Mild